This document provides an analysis of the global sterile injectables market from 2013 to 2023. It covers market segments by molecule type (biologic, small molecule), drug type, indication, distribution channel, region, and country. The key regions covered are North America, Europe, APAC, and the rest of the world. It provides historical data from 2013-2017 and forecasts until 2023. It also analyzes major country markets and companies in the sterile injectables industry.

1. Global Sterile Injectables Market – Analysis By Molecule Type,
Drug Type, Indication, Distribution Channel, By Region, By Country
(2018 Edition) - Forecast to 2023
• By Molecule Type - Biologic, Small Molecule
• By Drug Type - Monoclonal Antibody, Insulin, Vaccine, Fusion
Protein, Immunoglobulin, Others
• By Indication - Oncological Disorders, Cardiovascular
Disorders. Neurological Disorders. Infectious Disorders,
Metabolic Disorders, Musculoskeletal Disorders ,Others
• By Distribution Channel- Hospital Pharmacy, Retail Pharmacy,
E-commerce
• By Region- APAC , North America, Europe and ROW
• By Country - United States, Canada, United Kingdom,
Germany, China, India, Japan, Brazil, Saudi Arabia
June 2018

2. Scope of the Report – Sterile Injectables Market
2
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Global
Market (By Value)           
By Molecule
Type, By Value
Biologic           
Small Molecule           
By Biologic Drug
Type, By value
Monoclonal Antibody           
Insulin           
Vaccines           
Fusion Proteins           
Immunoglobulin           
Others           
By Indication, By
Value
Oncological Disorders           
Cardiovascular Disorders           
Metabolic Disorders           
Neurological Disorders           
Musculoskeletal Disorders
Infectious Disorders           
Others           
By Distribution
Channel, By Value
Hospitals           
Retail Pharmacies           
Online Pharmacies           
Regional
Market (By Value)           
By Molecule
Type, By Value
Biologic           
Small Molecule           
By Biologic Drug
Type, By value
Monoclonal Antibody           
Insulin           
Vaccines           
Fusion Proteins           
Immunoglobulin           
Others           
By Distribution
Channel, By Value
Hospitals           
Retail Pharmacies           
Online Pharmacies           
Historical Forecast

3. Scope of the Report – Sterile Injectables Market
3
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Regional
By Indication, By
Value
Oncological Disorders           
Cardiovascular Disorders           
Metabolic Disorders           
Neurological Disorders           
Musculoskeletal Disorders           
Infectious Disorders
Others           
Country
Market (By Value)           
By Molecule
Type, By Value
Biologic           
Small Molecule           
By Indication, By
Value
Cancer           
Cardiovascular           
Diabetes           
Central Nervous System           
Infectious Disorders           
Infectious Disorders
Others           
Company Analysis Pfizer, Novartis, Baxter International, Sanofi, Astra Zeneca, GlaxoSmithKline, Gilead Sciences, Merck&Co
Regional Analysis North America, Europe, APAC, Rest of World
Country Analysis US, Canada,UK, Germany,France, Brazil, Saudi Arabia, China, India, Japan
Historical Forecast

4. Table of Content
4
S.No Particulars
Page
No.
1. Research Methodology 24
2. Executive Summary 25
3. Strategic Recommendation 26
3.1 Focus on Asia Pacific Region 27
3.2 Focus on Technological Advancements 28
4 Sterile Injectables Outlook 29
5 Global Sterile Injectables: Growth and Forecast 34
5.1 By Value (2013-2017) 35
5.2 By Value (2018-2023) 36
6 Global Sterile Injectables Market – Segmental Analysis
6.1 Global Sterile Injectables Market – By Molecule Type 41
6.1.1 By Type, 2017 (%) 42
6.1.2 By Type, 2023 (%) 43
6.2 Global Biologic Sterile Injectables Market, By Value (2013-2023) 44
6.3 Global Small Molecule Sterile Injectables Market, By Value (2013-2023) 45
6.4 Global Sterile Injectables Market – By Biologic Drug Type 46

5. Table of Content
5
S.No Particulars
Page
No.
6.4.1 By Type, 2017 (%) 47
6.4.2 By Type, 2023 (%) 48
6.5 Global Monoclonal Antibody Sterile Injectables Market, By Value (2013-2023) 49
6.6 Global Insulin Sterile Injectables Market, By Value (2013-2023) 55
6.7 Global Vaccines Sterile Injectables Market, By Value (2013-2023) 60
6.8 Global Fusion Proteins Sterile Injectables Market, By Value (2013-2023) 65
6.9 Global Immunoglobulins Sterile Injectables Market, By Value (2013-2023) 66
6.10 Global Others Biologic Sterile Injectables Market, By Value (2013-2023) 67
6.11 Global Sterile Injectables Market – By Indication 68
6.11.1 By Indication, 2017 (%) 69
6.11.2 By Indication, 2023 (%) 70
6.12 Global Sterile Injectables For Oncological Disorders Market, By Value (2013-2023) 71
6.13 Global Sterile Injectables For Infectious Disorders Market, By Value (2013-2023) 73
6.14 Global Sterile Injectables For Metabolic Disorders Market, By Value (2013-2023) 76
6.15 Global Sterile Injectables For Cardiovascular Disorders Market, By Value (2013-2023) 78

6. Table of Content
6
S.No Particulars
Page
No.
6.16 Global Sterile Injectables For Neurological Disorders Market, By Value (2013-2023) 80
6.17 Global Sterile Injectables For Musculoskeletal Disorders Market, By Value (2013-2023) 82
6.18 Global Others Indication Sterile Injectables Market, By Value (2013-2023) 84
6.19 Global Sterile Injectables Market – By Distribution Channel 86
6.19.1 By Distribution Channel, By Value, 2017 (%) 87
6.19.2 By Distribution Channel, By Value, 2023 (%) 88
6.20 Global Hospital Pharmacy Sterile Injectables Market, By Value (2013-2023) 89
6.21 Global Retail Pharmacy Sterile Injectables Market, By Value (2013-2023) 90
6.22 Global Ecommerce Sterile Injectables Market, By Value (2013-2023) 91
7. Global Sterile Injectables Market: Regional Analysis 93
7.1 Global Sterile Injectables Market Size, By Region : Breakdown (%)
7.1.1 By Region, By Value, 2017 (%) 94
7.1.2 By Region, By Value, 2023 (%) 95
7.2 North America Sterile Injectables Market: An Analysis 96
7.2.1 By Value (2013-2017) 97
7.2.2 By Value (2018-2023) 99

7. Table of Content
7
S.No Particulars
Page
No.
7.2.3 By Molecule Type, By Value (2013-2023) 101
7.2.4 By Biologic Drug Type, By Value (2013-2023) 102
7.2.5 By Indication, By Value (2013-2023) 103
7.2.6 By Distribution Channel, By Value (2013-2023) 107
7.3 North America Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%) 108
7.3.1 U.S Sterile Injectables Market, By Value (2013-2023) 109
7.3.2 U.S Sterile Injectables Market, By Indication, By Value (2013-2023) 111
7.3.3 Canada Sterile Injectables Market, By Value (2013-2023) 120
7.3.4 Canada Sterile Injectables Market, By Indication, By Value (2013-2023) 122
7.4 Europe Sterile Injectables Market: An Analysis 125
7.4.1 By Value (2013-2017) 126
7.4.2 By Value (2018-2023) 128
7.4.3 By Molecule Type, By Value (2013-2023) 130
7.4.4 By Biologic Drug Type, By Value (2013-2023) 131
7.4.5 By Indication, By Value (2013-2023) 132

8. Table of Content
8
S.No Particulars
Page
No.
7.4.6 By Distribution Channel, By Value (2013-2023) 133
7.5 Europe Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%) 137
7.5.1 Germany Sterile Injectables Market, By Value (2013-2023) 139
7.5.2 Germany Sterile Injectables Market, By Indication, By Value (2013-2023) 140
7.5.3 United Kingdom Sterile Injectables Market, By Value (2013-2023) 144
7.5.4 United Kingdom Injectables Market, By Indication, By Value (2013-2023) 145
7.5.5 Rest of Europe Sterile Injectables Market, By Value (2013-2023) 149
7.7 APAC Sterile Injectables Market: An Analysis
7.7.1 By Value (2013-2017) 151
7.7.2 By Value (2018-2023) 153
7.7.3 By Molecule Type, By Value (2013-2023) 155
7.7.4 By Biologic Drug Type, By Value (2013-2023) 156
7.7.5 By Indication, By Value (2013-2023) 157
7.7.6 By Distribution Channel, By Value (2013-2023) 160

9. Table of Content
9
S.No Particulars
Page
No.
7.8 APAC Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%) 162
7.8.1 China Sterile Injectables Market, By Value (2013-2023) 164
7.8.2 China Sterile Injectables Market, By Indication, By Value (2013-2023) 167
7.8.3 Japan Sterile Injectables Market, By Value (2013-2023) 171
7.8.4 Japan Injectables Market, By Indication, By Value (2013-2023) 173
7.8.5 India Sterile Injectables Market, By Value (2013-2023) 177
7.8.6 India Injectables Market, By Indication, By Value (2013-2023) 178
7.8.7 Rest of APAC Sterile Injectables Market, By Value (2013-2023) 182
7.9 Rest of the World Sterile Injectables Market: An Analysis
7.9.1 By Value (2013-2017) 184
7.9.2 By Value (2018-2023) 185
7.9.3 By Molecule Type, By Value (2013-2023) 187
7.9.4 By Biologic Drug Type, By Value (2013-2023) 191

10. Table of Content
10
S.No Particulars
Page
No.
7.9.5 By Distribution Channel, By Value (2013-2023) 192
7.10 Rest of the World Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%) 194
7.5.1 Brazil Sterile Injectables Market, By Value (2013-2023) 196
7.5.2 Brazil Sterile Injectables Market, By Indication, By Value (2013-2023) 197
7.5.3 Saudi Arabia Sterile Injectables Market, By Value (2013-2023) 201
7.5.4 Saudi Arabia Injectables Market, By Indication, By Value (2013-2023) 202
7.5.5 Other Sterile Injectables Market, By Value (2013-2023) 206
8. Global Sterile Injectables Market Dynamics 207
8.1 Global Sterile Injectables Market Drivers 208
8.2 Global Sterile Injectables Market Restraints 211
9. Global Sterile Injectables Market Trends 213
10. Policy and Regulatory Landscape 215
11. Porter Five Force Analysis 223
12. SWOT Analysis 225

11. Table of Content
11
S.No Particulars
Page
No.
13. Company Profile 227
13.1 Sanofi 228
13.2 Pfizer 229
13.3 Baxer International 231
13.4 Glaxosmithkline 233
13.5 Novartis 234
13.6 Gilead Sciences 236
13.7 Merck & Co. 238
13.8 Astra Zeneca 240
14. About Us 241

12. List of Figures
Figure No. Figure Title Page No.
Figure 1: Sterile Injectables Market By Type 31
Figure 2: Global Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 35
Figure 3: Global Sterile Injectables Market Size, By Value, Forecast, 2018-2023 (USD Billion) 36
Figure 4: Global Health Expenditure Per Capita,(2012-2016, USD Trillion) 37
Figure 5: Global Health Expenditure Per Capita, By Select Countries,(2016, USD) 37
Figure 6: Global Population Aged 65 and Above, 2012-2015 (% of Total) 38
Figure 7: Global Diabetic Population, By Region, 2015 (Billion) 38
Figure 8: Global Sterile Injectables Market Size, By Molecule Type, 2017 (%) 42
Figure 9: Global Sterile Injectables Market Size, By Molecule Type, 2023F (%) 43
Figure 10: Global Biologic Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 44
Figure 11: Global Biologic Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion) 44
Figure 12: Global Small Molecule Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 45
Figure 13: Global Small Molecule Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion) 45
Figure 14: Global Sterile Injectables Market Size, By Type, 2017 (%) 47
Figure 15: Global Therapeutic and Monitoring Devices Market Size, By Type, 2023F (%) 48
Figure 16: Global Monoclonal Antibody Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 49
Figure 17: Global Monoclonal Antibody Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion) 49
Figure 18: Global Insulin Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 55
Figure 19: Global Insulin Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion) 55
Figure 20: Top 10 Leading countries with diabetes Prevalence, Million, 2017 56
12

13. List of Figures
Figure No. Figure Title Page No.
Figure 21: Highest Revenue Generating Insulin Drugs in 2016 & 2017 56
Figure 22: Global Vaccines Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 60
Figure 23: Global Vaccines Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion) 60
Figure 24: Market Share of Leading Vaccines Manufacturers 61
Figure 25: Global Vaccine Doses Consumption, By Income Group (Million,2016) 61
Figure 26: Global Fusion Proteins Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 65
Figure 27: Global Fusion Proteins Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion) 65
Figure 28: Global Immunoglobulins Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 66
Figure 29: Global Immunoglobulins Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion) 66
Figure 30: Global Others Biologic Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 67
Figure 31: Global Others Biologic Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion) 67
Figure 32: Global Sterile Injectables Market Size, By Indication, 2017 (%) 69
Figure 33: Global Sterile Injectables Market Size, By Indication, 2023F (%) 70
Figure 34: Global Sterile Injectables For Oncological Disorders Market Size, By Value, 2013-2017 (USD Billion) 71
Figure 35: Global Sterile Injectables For Oncological Disorders Market Size, By Value 2018E-2023F (USD Billion) 71
Figure 36: Number of People With Cancer, By Type, 2016 (Million) 72
Figure 37: Global Sterile Injectables For Infectious Disorders Market Size, By Value, 2013-2017 (USD Billion) 73
Figure 38: Global Sterile Injectables For Infectious Disorders Market Size, By Value 2018E-2023F (USD Billion) 73
Figure 39: Global Prevalence of Different Type of Infectious Disorders (2016,%) 74
Figure 40: Global Prevalence of Infectious Disorders (2012-2016, Million) 74
13

14. List of Figures
Figure No. Figure Title Page No.
Figure 41: Global Prevalence of Neglected Tropical Disorders in (2012-2016, Million) 75
Figure 42: Global Prevalence of Neglected Tropical Disorders, By Type (2016,%) 75
Figure 43: Global Sterile Injectables For Metabolic Disorders Market Size, By Value, 2013-2017 (USD Billion) 76
Figure 44: Global Sterile Injectables For Metabolic Disorders Market Size, By Value 2018E-2023F (USD Billion) 76
Figure 45: Global Diabetes Prevalence (2017&2045, Million) 77
Figure 46: Global Sterile Injectables For Cardiovascular Disorders Market Size, By Value, 2013-2017 (USD Billion) 78
Figure 47: Global Sterile Injectables For Cardiovascular Disorders Size, By Value 2018E-2023F (USD Billion) 78
Figure 48: Cardiovascular Disease Prevelance, By Type ,2016 79
Figure 49: Global Prevalence of Cardiovascular Disease (2012-2016 , Million) 79
Figure 50: Global Sterile Injectables For Neurological Disorders Market Size, By Value, 2013-2017 (USD Billion) 80
Figure 51: Global Sterile Injectables For Neurological Disorders Market Size,, By Value 2018E-2023F (USD Billion) 80
Figure 52: Neurological Disorders Prevalence, By Type ,2016 81
Figure 53: Global Prevalence of Neurological Disorders (2012-2016 , Billion) 81
Figure 54: Global Sterile Injectables For Musculoskeletal Disorders Market Size, By Value, 2013-2017 (USD Billion) 82
Figure 55: Global Sterile Injectables For Musculoskeletal Disorders Market Size, By Value 2018E-23F (USD Billion) 82
Figure 56: Musculoskeletal Disorders Prevalence, By Type , 2016 83
Figure 57: Global Prevalence of Musculoskeletal Disorders (2012-2016 , Billion) 83
Figure 58: Global Others Indication Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 84
Figure 59: Global Others Indication Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion) 84
Figure 60: Global Prevalence of Gynecological Disorder (2012-2016, Million) 85
14

15. List of Figures
Figure No. Page No.
Figure 61: Global Prevalence of Gynecological Disorder, By Type 2016 85
Figure 62: Global Prevalence of Sense Organ Disorder (2012-2016, Million) 85
Figure 63: Global Sterile Injectables Market Size, By Distribution Channel, 2017 (%) 87
Figure 64: Global Sterile Injectables Market Size, By Distribution Channel, 2023F (%) 88
Figure 65: Global Hospital Pharmacy Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 89
Figure 66: Global Hospital Pharmacy Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion) 89
Figure 67: Global Retail Pharmacy Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 90
Figure 68: Global Retail Pharmacy Sterile Injectables Market Size, , By Value 2018E-2023F (USD Billion) 90
Figure 69: Global Ecommerce Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 91
Figure 70: Global Ecommerce Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion) 91
Figure 71: Percentage of Oncology Drugs Distributed Through Various Channels 92
Figure 72: Global Sterile Injectables Market Size and Share, By Region, 2017 94
Figure 73: Global Sterile Injectables Market Size and Share, By Region, 2023F 95
Figure 74: North America Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 97
Figure 75: Number of deaths due to cancer in North America 98
Figure 76: North America Population above 65 year in Million 98
Figure 77: North America Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion ) 99
Figure 78: North America Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion) 101
Figure 79: North America Sterile Injectables Market : By Biologic Drug Type, By Value, 2013-2023 (USD Billion) 102
Figure 80: North America Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion) 103
15

16. List of Figures
Figure No. Figure Title Page No.
Figure 81: North America Prevalence of Neurological Disorder (2012-2016, Million) 105
Figure 82: North America Prevalence of Neurological Disorder, By Type 2016 105
Figure 83: North America Prevelnace of Musculoskeletal Disorders (2012-2016, Million) 105
Figure 84: North America Prevalence of Gynecological Disorders (2012-2016) 106
Figure 85: Total Number of People with North America Neglected Tropical Disorders (2012-2016) 106
Figure 86: Total Number of People in North America with Different Type of Cardiovascular Disease in 2016 106
Figure 87: North America Sterile Injectables Market : By Distribution Channel, By Value, 2013-2023 (USD Billion) 107
Figure 88: North America Sterile Injectables Market, Country Share, 2017 (% of Total) 109
Figure 89: North America Sterile Injectables , Country Share, 2023 (% of Total) 109
Figure 90: United States Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 111
Figure 91: United States Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion) 111
Figure 92: U.S. Per Capita Health Expenditure, 2012-2016 ( USD) 112
Figure 93: U.S. Population Ages 65 and above, 2014 and Forecast (Million) 112
Figure 94: Per Capita Healthcare Expenditure in United States (2012-2016, USD) 113
Figure 95: U.S Health Spending by Type of Service or Product, 2016 (%) 113
Figure 96: United Sates Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion) 114
Figure 97: United States Prevalence of Cardiovascular Disorders, By Type in 2016 116
Figure 98: New Estimated Cases of Cancer in United States (2014-2018) 116
Figure 99: New Estimated Cases of Cancer in United States, By Gender 2018 116
Figure 100: New Estimated Cases of Cancer in United States, By Type 2018 117
16

17. List of Figures
Figure No. Figure Title Page No.
Figure 101: United States Prevalence of Diabetes (Per 1,00,000 )2013-2016 118
Figure 102: United States Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016 118
Figure 103: Prevalence of Neurological Disorders in United States (2016, Million) 118
Figure 104: United States Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016 118
Figure 105: Canada Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 120
Figure 106: Canada Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion) 120
Figure 107: Canada Per Capita Health Expenditure, 2012-2016 ( USD) 121
Figure 108: Canada Population Ages 65 and above, (% of Total,2012-2016) 121
Figure 109: Canada Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion) 122
Figure 110: Canada Prevalence of Diabetes (Per 1,00,000 )2013-2016 124
Figure 111: Canada Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016 124
Figure 112: Canada Total Number of People With Sense Organ Disorders (2012-2016) 124
Figure 113: Canada Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016 124
Figure 114: Europe Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 126
Figure 115: Percentage of Male and Female deaths due to cancer in EU 28 2016 127
Figure 116: Europe Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion ) 128
Figure 117: Europe Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion) 130
Figure 118: Europe Sterile Injectables Market : By Biologic Drug Type, By Value, 2013-2023 (USD Billion) 131
Figure 119: Europe Sterile Injectables Market : By Distribution Channel, By Value, 2013-2023 (USD Billion) 132
Figure 120: Europe Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion) 133
17

18. List of Figures
Figure No. Figure Title Page No.
Figure 121: Western Europe Prevalence of Gynecological (2012-2016, Million) 135
Figure 122: Western Europe Prevalence of Musculoskeletal Disorders (2012-2016, Million) 135
Figure 123: Total Number of People With Cardiovascular Disorders in Western Europe, By Type,2016 135
Figure 124: Europe Sterile Injectables Market, Country Share, 2017 (% of Total) 137
Figure 125: Europe Sterile Injectables Market, Country Share, 2023 (% of Total) 137
Figure 126: Germany Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 139
Figure 127: Germany Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion) 139
Figure 128: Germany Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion) 140
Figure 129: Germany Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016 142
Figure 130: United Kingdom Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 142
Figure 131: Germany Prevalence of Neurological Disorders (2012-2016, Million) 142
Figure 132: Germany Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016 142
Figure 133: United Kingdom Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 144
Figure 134: United Kingdom Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion) 144
Figure 135: United Kingdom Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion) 145
Figure 136: Estimated Number of People Living with cancer in United Kingdom 146
Figure 137: United Kingdom Prevalence of Diabetes Mellitus (Per 1,00,000 )2013-2016 147
Figure 138: United Kingdom Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016 147
Figure 139: United Kingdom Prevalence of Disorders (Per 1,00,000 )2013-2016 147
Figure 140: Rest of Europe Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 149
18

19. List of Figures
Figure No. Figure Title Page No.
Figure 141: Rest of Europe Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion) 149
Figure 142: Asia Pacific Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 151
Figure 143: Ranking of countries from Asia-Pacific in the Global Access to Healthcare Index 152
Figure 144: Mobile health revenue forecast in Asia Pacific in 2017, by country (in billion U.S. dollars) 152
Figure 145: Asia Pacific Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion ) 153
Figure 146: Asia Pacific Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion) 155
Figure 147: Asia Pacific Sterile Injectables Market : By Biologic Drug Type, By Value, 2013-2023 (USD Billion) 156
Figure 148: Asia Pacific Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion) 157
Figure 149: Prevalence of Neurological Disorders in South East Asia, East Asia and Oceania ,2012-2016,Million 159
Figure 150: Prevalence of Musculoskeletal Disorders in South East Asia, East Asia and Oceania ,(2012-2016, Million) 159
Figure 151: Total Number of People With Cardiovascular Disorders in South East Asia, East Asia and Oceania , By
Type,2016
159
Figure 152: Asia Pacific Sterile Injectables Market : By Distribution Channel, By Value, 2013-2023 (USD Billion) 160
Figure 153: Asia Pacific Sterile Injectables Market, Country Share, 2017 (% of Total) 162
Figure 154: Asia Pacific Sterile Injectables, Country Share, 2023 (% of Total 162
Figure 155: China Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 164
Figure 156: China Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion) 164
Figure 157: China Healthcare Expenditure (2012-2016, USD Billion) 165
Figure 158: China Population 65 Years & Above (% of Total),2012-2016 ) 165
Figure 159: China Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion) 169
Figure 160: China Prevalence of Diabetes Mellitus (Per 1,00,000 )2013-2016 169
19

20. List of Figures
Figure No. Figure Title Page No.
Figure 161: China Prevalence of Disorders (Per 1,00,000 )2013-2016 169
Figure 162: China Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016 169
Figure 163: Japan Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 171
Figure 164: Japan Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion) 171
Figure 165: Japan Per Capita Health Expenditure (2012-2016,USD) 172
Figure 166: Japan Population 65 Years & Above (% of Total), 2012-2016 172
Figure 167: Japan Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion) 173
Figure 168: Japan Prevalence of Diabetes Mellitus (Per 1,00,000 )2013-2016 175
Figure 169: Japan Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016 175
Figure 170: Japan Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016 175
Figure 171: India Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 177
Figure 172: India Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion) 177
Figure 173: India Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion) 178
Figure 174: India Prevalence of Diabetes Mellitus Per 1,00,000 )2013-2016 180
Figure 175: India Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016 80
Figure 176: India Prevalence of Cardiovascular Disorders (Per 1,00,000) 2013-2016 180
Figure 177: Total Number of People With Infectious Disorder in India (2012-2016) 180
Figure 178: Rest of Asia Pacific Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 182
Figure 179: Rest of Asia Pacific Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion) 182
Figure 180: Rest of World Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 184
20

21. List of Figures
Figure No. Figure Title Page No.
Figure 181: Rest of World Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion ) 185
Figure 182: Rest of World Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion) 187
Figure 183: Rest of World Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion) 188
Figure 184: Prevalence of Infectious Disorder in Middle East and North Africa Region (2012-2016, Million) 190
Figure 185: Prevalence of Infectious Disorder in Middle East and North Africa Region (2012-2016, Million) 190
Figure 186: Prevalence of Sense Organ Disorders in Middle East and North Africa Region (2012-2016, Million) 190
Figure 187: Rest of World Sterile Injectables Market : By Biologic Drug Type, By Value, 2013-2023 (USD Billion) 191
Figure 188: Rest of World Sterile Injectables Market : By Distribution Channel, By Value, 2013-2023 (USD Billion) 192
Figure 189: Rest of World Sterile Injectables Market, Country Share, 2017 (% of Total) 194
Figure 190: Rest of World Sterile Injectables , Country Share, 2023 (% of Total) 194
Figure 191: Brazil Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 196
Figure 192: Brazil Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion) 196
Figure 193: Brazil Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion) 197
Figure 194: Brazil Prevalence of Diabetes (Per 1,00,000 )2013-2016 199
Figure 195: Brazil Prevalence of Disorders (Per 1,00,000 )2013-2016 199
Figure 196: Brazil Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016 199
Figure 197: Total Number of People With Infectious Disorder in Brazil (2012-2016) 199
Figure 198: Saudi Arabia Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 201
Figure 199: Saudi Arabia Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion) 201
Figure 200: Saudi Arabia Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion) 202
21

22. List of Figures
Figure No. Figure Title Page No.
Figure 201: Saudi Arabia Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016 203
Figure 202: Saudi Arabia Prevalence of Diabetes (Per 1,00,000 )2013-2016 204
Figure 203: Saudi Arabia Prevalence of Disorders (Per 1,00,000 )2013-2016 204
Figure 204: Total Number of People With Infectious Disorder in Saudi Arabia (2012-2016) 204
Figure 205: Others Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion) 206
Figure 206: Others Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion) 206
Figure 207: Pfizer, Revenue, 2015-2017 (USD Millions) 230
Figure 208: Pfizer Segmental Breakup, 2017 (%) 230
Figure 209: Pfizer Sales, By Country, 2017 (%) 230
Figure 210: Baxter International, Revenues, 2014-2016 (USD Billion) 232
Figure 211: Baxter International, Net Sales, By Segment, 2016 (%) 232
Figure 212: Baxter International, Net Sales, By Region, 2016 (%) 232
Figure 213: Novartis, Sales, 2013-2017 (USD Millions) 235
Figure 214: Novartis Sales, By Segment 2017 (%) 235
Figure 215: Novartis Sales, By Geography,2017 (%) 235
Figure 216: Gilead Sciences Product Sales, 2016 (%) 237
Figure 217: Gilead Sciences HCV Product Sales, 2014-2016 (USD Billion) 237
Figure 218: Net Sales, By Geographic Location, % Share 2016 239
Figure 219: Net Revenue, By Business Segment, % Share 2017 239
Figure 220: Net Sales, 2014-2017 (In million USD) 239
22

23. List of Figures
Figure No. Figure Title Page No.
Table 1: Recent Mergers and Collaborations in Sterile Injectables Industry 40
Table 2: List of Some Monoclonal Antibody Drugs Available in Market 50
Table 3: Antibody therapeutics in late-stage clinical studies for non-cancer indications. 51
Table 4: Antibody therapeutics in late-stage clinical studies for non-cancer indications. 52
Table 5: Antibody therapeutics in late-stage clinical studies for Cancer Indications. 53
Table 6: Antibody therapeutics in late-stage clinical studies for Cancer Indications 54
Table 7: List of Some Insulin Sterile Injectables Drugs Available in Market 57
Table 8: List of Some Insulin Sterile Injectables Drugs Available in Market 58
Table 9: List of Insulin Manufacturers, in Selected Countries 59
Table 10: GlaxoSmithKline Vaccine Pipeline 62
Table 11: Pfizer Vaccine Pipeline 64
23

24. Research Methodology
Research Definition
Global Sterile Injectables Report comprises of the study of various aspects of Sterile Injectables Market
and forecast until 2023. Global Sterile Injectables has been segmented By Molecule Type (Biologic, Small
Molecule), By Drug Type (Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin,
Others), By Indication (Oncological Disorders, Cardiovascular Disorders. Neurological Disorders.
Infectious Disorders, Metabolic Disorders, Musculoskeletal Disorders, Others), By Distribution Channel
(Hospital Pharmacy, Retail Pharmacy, E-commerce), By Region (North America, Europe, APAC and ROW)
and By Country (U.S., Canada, Germany, United Kingdom, China, India, Japan, Brazil, Saudi Arabia).
Data Analysis and Interpretation
Our historic market trend has been figured out by various paid databases which was further triangulated
with inputs and insights from industry experts, companies and stakeholders, through primary research
(manufacturers, marketing managers, others). Back-of-the-Envelope calculation for the market estimation
has been made through proper understanding of the market as well as future business strategies of the
companies operating in the market.
Azoth Analytics has conducted quantitative as well as qualitative research to gather market insights such as market sizing,
market segmentation, recent trends and developments and competitive landscape. Our team has conducted extensive
primary surveys by reaching out industry experts across the value chain of the global sterile injectable market.
24

25. Global Sterile Injectables Overview
Source: Azoth Analytics Estimates
Xx
Xx
Xx
Xx
Xx
Global Sterile Injectables Market has been boosted by the growing aging population and
increasing demand for novel drug delivery system.
2013 2014 2015 2016 2017
Figure 2: Global Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
CAGR 2013-2017
xx%
25

26. Global Sterile Injectables Overview
Robust biologic pipeline, increase focus on merger and acquisitions likely to drive the demand growth
during forecast period
2018 2019 2020 2021 2022 2023
Source: Azoth Analytics Estimates
CAGR 2018-2023
x%
Figure 3: Global Sterile Injectables Market Size, By Value, Forecast, 2018-2023 (USD Billion)
26
Xx
Xx
Xx
Xx
Xx

27. Global Sterile Injectables Market-By Biologic Drug Type
Figure 14: Global Sterile Injectables Market Size, By Type, 2017 (%)
Monoclonal antibody segment held the majority market share of approximately 37.63 %, by value, in the
year 2017.
Source: Azoth Analytics Estimates
Key Drivers
Monoclonal
Antibody
Insulin
Vaccines
Fusion Proteins
Immunoglobulins
Others
xx
xx
27

28. • .
28
Source: Azoth Analytics Estimates
CAGR 2013-2017
xx%
CAGR 2018-2023
xx%
Global Biologic Sterile Injectables Market
Figure 10: Global Biologic Sterile Injectables Market
Size, By Value, 2013-2017 (USD Billion)
Figure 11: Global Biologic Sterile Injectables
Market Size, By Value 2018E-2023F (USD Billion)
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Xx
Xx
Xx
Xx
Xx

29. Global Sterile Injectables Market-By Indication
Figure 33: Global Sterile Injectables Market Size, By Indication, 2023F
(%)
Source: Azoth Analytics Estimates
Key Drivers
xx
xx
During forecast period, Other Segment are expected to witness fastest growing segment during forecast
period.
29
Oncological
Disorders
Infectious
Disorders
Metabolic
Disorders
Cardiovascular
Disorders
Neurological
Disorders
Musculoskeletal
Disorders
Others

30. Asia Pacific Sterile Injectables Market Overview
Source: Azoth Analytics Estimates
2013 2014 2015 2016 2017
Figure 142: Asia Pacific Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
CAGR 2013-2017
x%
30
Xx
Xx
Xx
Xx
Xx
xx
Rising number of old age population as well as growing healthcare expenditure has backed sterile
injectables market of Asian pacific region.

31. Asia Pacific Sterile Injectables Market Overview
2018 2019 2020 2021 2022 2023
Source: Azoth Analytics Estimates
CAGR 2018-2023
x%
Figure 145: Asia Pacific Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion )
31
Increasing participation of private players coupled with emergence of CMO industry will drive the market
for sterile injectable in the region.
Xx
Xx
Xx
Xx
Xx
xx

32. Source: Azoth Analytics Estimates
Figure 146: Asia Pacific Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion)
CAGR 2013-2017
Biologic : x%
Small Molecule: x %
Asia Pacific Sterile Injectables Market, By Molecule Type
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Biologic 35.01 36.81 38.70 40.68 42.77 46.35 49.95 53.59 57.26 60.97 64.70
Small Molecule 22.73 24.03 25.41 26.86 28.40 30.87 33.38 35.93 38.52 41.14 43.80
CAGR 2013-2017
Biologic : x%
Small Molecule:: x%
32
Xx
Xx
Xx
Xx
Xx
xx

33. Source: Azoth Analytics Estimates
Figure 147: Asia Pacific Sterile Injectables Market : By Biologic Drug Type, By Value, 2013-2023 (USD Billion)
CAGR 2013-2017
Monoclonal antibody :x%
Insulin:: x%
Vaccine:: x%
Fusion Proteins: x7%
Immunoglobulins: x%
Others:: x%
Asia Pacific Sterile Injectables Market, By Biologic Drug Type
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Monoclonal Antibody 13.88 14.58 15.30 16.07 16.87 18.27 19.68 21.11 22.54 23.99 25.45
Insulin 5.58 5.80 6.03 6.26 6.50 7.03 7.56 8.09 8.63 9.17 9.71
Vaccines 6.52 6.85 7.19 7.55 7.93 8.57 9.21 9.85 10.50 11.14 11.79
Fusion Proteins 2.09 2.20 2.31 2.43 2.56 2.78 3.00 3.22 3.44 3.67 3.90
Immunoglobulins 1.01 1.07 1.13 1.20 1.27 1.38 1.51 1.63 1.76 1.89 2.02
Others 5.92 6.31 6.73 7.17 7.64 8.31 9.00 9.69 10.40 11.12 11.85
CAGR 2013-2017
Monoclonal antibody :x%
Insulin: x%
Vaccine:: x%
Fusion Proteins: x%
Immunoglobulins: x%
Others: x%
Xx
xx
33

34. Source: Azoth Analytics Estimates
Figure 148: Asia Pacific Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion)
CAGR 2013-2017
Oncological Disorders:x%; Infectious Disorders: x%;
Metabolic Disorders: x%;Cardiovascular Disorders:
x%;Neurological Disorders: x%
Musculoskeletal Disorders :x%; Others: x%;
Asia Pacific Sterile Injectables Market, By Indication
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Oncological Disorders 6.13 6.40 6.68 6.97 7.27 8.52 9.14 9.77 10.39 11.01 11.64
Infectious Disorders 5.68 5.95 6.23 6.52 6.83 7.85 8.42 8.99 9.56 10.12 10.69
Metabolic Disorders 5.97 6.30 6.65 7.02 7.41 7.85 8.47 9.09 9.72 10.35 10.99
Cardiovascular Disorders 7.18 7.54 7.91 8.31 8.73 9.41 10.14 10.89 11.64 12.40 13.17
Neurological Disorders 5.50 5.81 6.13 6.48 6.84 5.82 6.29 6.76 7.24 7.72 8.22
Musculoskeletal Disorders 4.42 4.68 4.96 5.26 5.58 3.69 4.00 4.31 4.62 4.94 5.27
Others 22.86 24.17 25.53 26.98 28.50 34.08 36.88 39.72 42.61 45.55 48.53
CAGR 2013-2017
Oncological Disorders: x%; Infectious Disorders: x%;
Metabolic Disorders: x%;Cardiovascular Disorders:
x%;Neurological Disorders: x%
Musculoskeletal Disorders :x%; Others: x%;
34

35. Source: Azoth Analytics Estimates
Figure 152: Asia Pacific Sterile Injectables Market : By Distribution Channel, By Value, 2013-2023 (USD Billion)
CAGR 2013-2017
Hospital Pharmacy:: x%
Retail Pharmacy: x%
Ecommerce:: x%
Asia Pacific Sterile Injectables Market, By Distribution Channel
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Hospital Pharmacy 46.60 49.09 51.70 54.46 57.36 62.20 67.10 72.05 77.05 82.10 87.20
Retail Pharmacy 7.89 8.32 8.78 9.26 9.76 10.61 11.47 12.35 13.23 14.13 15.04
Ecommerce 3.25 3.43 3.63 3.83 4.04 4.40 4.76 5.13 5.50 5.88 6.27
CAGR 2013-2017
Hospital Pharmacy:: x%
Retail Pharmacy: x%
Ecommerce:: x%
Xx
Xx
Xx
xx
35

36. About Azoth Analytics Pvt Ltd.
Azoth Analytics creates in-depth research reports by recording, interpreting and analyzing information through primary and secondary
research. Our strategic market sizing and data dredging techniques include secondary research, interviews with key market players and
industry experts and use of industry specific statistical tools which helps in designing and planning effective research for our global and
local clients. We provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and
gas, retail, telecommunications, real estate, logistics, energy, Health and Personal Care, technology, FMCG, food & beverages and media
sectors .
Related Reports:
1. Global Vitreoretinal Surgery Device Market: Trends, Opportunities and Forecasts (2016-2021)
(By Product Type (Vitrectomy Surgery Devices, Photocoagulation Surgery Devices, Illumination Devices ), By End User (Hospitals and Free
Standing Ambulatory Surgery Centers); By Region: N. America, Europe, APAC and ROW
2. Global Microinvasive Glaucoma Surgery Device Market: Trends, Opportunities and Forecasts (2017-2021)
• (By Target (Trabecular Meshwork, Suprachoroidal Space and Others) By Surgery (Glaucoma in Conjunction with Cataract, Standalone
Glaucoma By End User (Hospitals, ASCs); By Region: N. America, Europe, APAC and ROW
3. Global Heart Valve Market, By Region, By Country: Opportunities and Forecasts (2016-2021)
• (By Procedure- (Replacement and Repair) Replacement Procedure By Technique- (Mechanical, Bioprosthetic & TAVR) Repair Procedure
By Technique- (Surgical, Balloon Valvuloplasty & TMVR); By Region - United States, Canada, United Kingdom, Germany, France, China,
India, Japan, Brazil and Saudi Arabia)
Disclaimer: Azoth Analytics report information is based mainly on interviews and therefore, is subject to fluctuation. Azoth Analytics
therefore, takes no responsibility for any incorrect information supplied to us by industry experts, manufacturers or users. Azoth does not
warranty the completeness of the information and data. Also, analysis provided in the report are meant for customers’ internal use only
and not for general publication or disclosure to third parties.
36